Skip to content

Clinical trials

Observational Multiple Sclerosis, Relapsing-Remitting trials with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Sclerosis, Relapsing-Remitting Phase: Observational Status: Unknown status Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20121
20161
20181
20191
20201
20225
20231
20243

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status15

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Assiut University1
Centre d'Investigation Clinique et Technologique 8051
Friedemann Paul1
Hasselt University1
Heinrich-Heine University, Duesseldorf1
Instituto Jalisciense de Cancerologia1
Kessler Foundation1
McGill University1
NHS Greater Glasgow and Clyde1
Neuromed IRCCS1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Sclerosis, Relapsing-Remitting15
Multiple Sclerosis6
Multiple Sclerosis, Chronic Progressive2
Disease Progression1
Epstein-Barr Virus Infections1
Inflammation1
Influenza, Human1
Neuromyelitis Optica1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.